trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Lee SK et al. Silencing mediator of retinoic acid and thyroid hormone receptors, as a novel transcriptional corepressor molecule of activating protein-1, nuclear factor-kappaB, and serum response factor. 2000 J. Biol. Chem. pmid:10777532
Yu F et al. Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. 2000 Nucleic Acids Res. pmid:10773092
Yoshida M and Horinouchi S [Histone deacetylase inhibitors--new anticancer agents?]. 2000 Tanpakushitsu Kakusan Koso pmid:10771678
Hobbs CA and Gilmour SK High levels of intracellular polyamines promote histone acetyltransferase activity resulting in chromatin hyperacetylation. 2000 J. Cell. Biochem. pmid:10760944
Eickhoff B et al. Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. 2000 Biol. Chem. pmid:10746741
Avram D et al. Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. 2000 J. Biol. Chem. pmid:10744719
Sirchia SM et al. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells. 2000 Oncogene pmid:10734315
Siavoshian S et al. Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression. 2000 Gut pmid:10716680
Adachi N et al. Cell-cycle regulation of the DNA topoisomerase IIalpha promoter is mediated by proximal CCAAT boxes: possible involvement of acetylation. 2000 Gene pmid:10713444
Yu J et al. Transcriptional repression by blimp-1 (PRDI-BF1) involves recruitment of histone deacetylase. 2000 Mol. Cell. Biol. pmid:10713181
Ruh MF et al. The effects of histone acetylation on estrogen responsiveness in MCF-7 cells. 1999 Endocrine pmid:10709763
Imai S et al. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. 2000 Nature pmid:10693811
Stöckel B et al. Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene. 2000 Eur. J. Biochem. pmid:10691972
Shin JY et al. Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. 2000 Cancer Res. pmid:10667572
Kim YB et al. Selective induction of cyclin-dependent kinase inhibitors and their roles in cell cycle arrest caused by trichostatin A, an inhibitor of histone deacetylase. 1999 Ann. N. Y. Acad. Sci. pmid:10667219
Sowa Y et al. Histone deacetylase inhibitor activates the p21/WAF1/Cip1 gene promoter through the Sp1 sites. 1999 Ann. N. Y. Acad. Sci. pmid:10667218
Yoshida M and Horinouchi S Trichostatin and leptomycin. Inhibition of histone deacetylation and signal-dependent nuclear export. 1999 Ann. N. Y. Acad. Sci. pmid:10667200
Garrison PM et al. Effects of histone deacetylase inhibitors on the Ah receptor gene promoter. 2000 Arch. Biochem. Biophys. pmid:10666294
Hodny Z et al. Sp1 and chromatin environment are important contributors to the formation of repressive chromatin structures on the transfected human adenine nucleotide translocase-2 promoter. 2000 Biochem. J. pmid:10657244
Smith RD et al. Quantitative PCR analysis of HbF inducers in primary human adult erythroid cells. 2000 Blood pmid:10648397
Marenzi S et al. Efficiency of expression of transfected genes depends on the cell cycle. 1999 Mol. Biol. Rep. pmid:10634509
Xiao H et al. p300 collaborates with Sp1 and Sp3 in p21(waf1/cip1) promoter activation induced by histone deacetylase inhibitor. 2000 J. Biol. Chem. pmid:10625687
Chen WY and Townes TM Molecular mechanism for silencing virally transduced genes involves histone deacetylation and chromatin condensation. 2000 Proc. Natl. Acad. Sci. U.S.A. pmid:10618426
Gray SG et al. Modulating IGFBP-3 expression by trichostatin A: potential therapeutic role in the treatment of hepatocellular carcinoma. 2000 Int. J. Mol. Med. pmid:10601571
Taddei A et al. Duplication and maintenance of heterochromatin domains. 1999 J. Cell Biol. pmid:10601331
Chien PY et al. A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells. 1999 Mol. Endocrinol. pmid:10598586
Gray SG et al. IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cells. 1999 Exp. Cell Res. pmid:10585285
Jung M et al. Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation. 1999 J. Med. Chem. pmid:10579829
Schmidt K et al. Inhibitors of histone deacetylase suppress the growth of MCF-7 breast cancer cells. 1999 Arch. Pharm. (Weinheim) pmid:10575368
Habeck M Gelsolin: a new marker for breast cancer? 1999 Mol Med Today pmid:10562712
Nielsen AL et al. Interaction with members of the heterochromatin protein 1 (HP1) family and histone deacetylation are differentially involved in transcriptional silencing by members of the TIF1 family. 1999 EMBO J. pmid:10562550
Bordonaro M et al. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. 1999 Cell Growth Differ. pmid:10547075
Vanden Berghe W et al. The nuclear factor-kappaB engages CBP/p300 and histone acetyltransferase activity for transcriptional activation of the interleukin-6 gene promoter. 1999 J. Biol. Chem. pmid:10542243
Rüller S et al. Sensitization of tumor cells to ribotoxic stress-induced apoptotic cell death: a new therapeutic strategy. 1999 Clin. Cancer Res. pmid:10537334
Carmen AA et al. Yeast HOS3 forms a novel trichostatin A-insensitive homodimer with intrinsic histone deacetylase activity. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10535926
List HJ et al. Inhibition of histone deacetylation augments dihydrotestosterone induction of androgen receptor levels: an explanation for trichostatin A effects on androgen-induced chromatin remodeling and transcription of the mouse mammary tumor virus promoter. 1999 Exp. Cell Res. pmid:10527637
Murphy M et al. Transcriptional repression by wild-type p53 utilizes histone deacetylases, mediated by interaction with mSin3a. 1999 Genes Dev. pmid:10521394
Gobl AE et al. Menin represses JunD-activated transcription by a histone deacetylase-dependent mechanism. 1999 Biochim. Biophys. Acta pmid:10500243
Huang Y et al. Transcriptional repression by REST: recruitment of Sin3A and histone deacetylase to neuronal genes. 1999 Nat. Neurosci. pmid:10491605
Finnin MS et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors. 1999 Nature pmid:10490031
Sowa Y et al. Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. 1999 Cancer Res. pmid:10485470
Kosugi H et al. Histone deacetylase inhibitors are the potent inducer/enhancer of differentiation in acute myeloid leukemia: a new approach to anti-leukemia therapy. 1999 Leukemia pmid:10482980
Ng HH et al. MBD2 is a transcriptional repressor belonging to the MeCP1 histone deacetylase complex. 1999 Nat. Genet. pmid:10471499
Bernhard D et al. Interaction between dexamethasone and butyrate in apoptosis induction: non-additive in thymocytes and synergistic in a T cell-derived leukemia cell line. 1999 Cell Death Differ. pmid:10453071
Zabel MD et al. Lymphoid transcription of the murine CD21 gene is positively regulated by histone acetylation. 1999 J. Immunol. pmid:10453011
Liu Z et al. Steroid receptor coactivator-1 (SRC-1) enhances ligand-dependent and receptor-dependent cell-free transcription of chromatin. 1999 Proc. Natl. Acad. Sci. U.S.A. pmid:10449719
KraevskiÄ­ VA and Prasolov VS [Comparative analysis of higher levels of organization of normal and hyperacetylated chromatin]. 1999 Dokl. Akad. Nauk. pmid:10439916
Tagami T et al. Mechanisms that mediate negative regulation of the thyroid-stimulating hormone alpha gene by the thyroid hormone receptor. 1999 J. Biol. Chem. pmid:10428804
Suzuki T et al. Synthesis and histone deacetylase inhibitory activity of new benzamide derivatives. 1999 J. Med. Chem. pmid:10425110
Ghosh AK et al. MBP-1 physically associates with histone deacetylase for transcriptional repression. 1999 Biochem. Biophys. Res. Commun. pmid:10403782